We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$4.31B
AUM Growth
+$222M
Cap. Flow
+$277M
Cap. Flow %
6.44%
Top 10 Hldgs %
18.96%
Holding
2,575
New
116
Increased
713
Reduced
638
Closed
110

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Financials 3.89%
3 Industrials 3.72%
4 Healthcare 2.96%
5 Energy 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBRA icon
1101
Zebra Technologies
ZBRA
$13.2B
$128K ﹤0.01%
613
-49
-7% -$11.5K
PMAR icon
1102
Innovator US Equity Power Buffer ETF March
PMAR
$757M
$127K ﹤0.01%
2,850
FXU icon
1103
First Trust Utilities AlphaDEX Fund
FXU
$838M
$127K ﹤0.01%
2,557
+401
+19% +$19.3K
ARES icon
1104
Ares Management
ARES
$28.9B
$125K ﹤0.01%
+1,150
New +$153K
NOG icon
1105
Northern Oil and Gas
NOG
$2.16B
$125K ﹤0.01%
4,280
SON icon
1106
Sonoco
SON
$5.99B
$125K ﹤0.01%
2,310
BIO icon
1107
Bio-Rad Laboratories Class A
BIO
$8.84B
$125K ﹤0.01%
448
-35
-7% -$10.1K
VTWO icon
1108
Vanguard Russell 2000 ETF
VTWO
$17.4B
$125K ﹤0.01%
1,247
+369
+42% +$38.5K
SW
1109
Smurfit Westrock
SW
$26.7B
$124K ﹤0.01%
3,122
-48
-2% -$2.07K
PEG icon
1110
Public Service Enterprise Group
PEG
$39.4B
$124K ﹤0.01%
1,529
-294
-16% -$24.1K
BBSC icon
1111
JPMorgan BetaBuilders US Small Cap Equity ETF
BBSC
$702M
$124K ﹤0.01%
1,646
-161
-9% -$12.5K
MET icon
1112
MetLife
MET
$62.7B
$123K ﹤0.01%
1,744
-155
-8% -$11.6K
HSCZ icon
1113
iShares Currency Hedged MSCI EAFE Small-Cap ETF
HSCZ
$240M
$123K ﹤0.01%
3,102
+2,570
+483% +$104K
OTIS icon
1114
Otis Worldwide
OTIS
$28.1B
$122K ﹤0.01%
1,584
SGOL icon
1115
abrdn Physical Gold Shares ETF
SGOL
$6.87B
$121K ﹤0.01%
2,712
ICSH icon
1116
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.06B
$121K ﹤0.01%
2,387
-7
-0.3% -$354
PYPL icon
1117
PayPal
PYPL
$51.7B
$121K ﹤0.01%
2,671
+104
+4% +$5.02K
CRL icon
1118
Charles River Laboratories
CRL
$11.5B
$121K ﹤0.01%
700
-41
-6% -$7.6K
CGIB
1119
Capital Group International Bond ETF USD-Hedged
CGIB
$292M
$121K ﹤0.01%
4,781
+2,393
+100% +$60.9K
NECB icon
1120
Northeast Community Bancorp
NECB
$380M
$120K ﹤0.01%
5,060
IWC icon
1121
iShares Micro-Cap ETF
IWC
$1.45B
$120K ﹤0.01%
754
-12,387
-94% -$2.05M
MTB icon
1122
M&T Bank
MTB
$36.6B
$120K ﹤0.01%
582
-150
-20% -$32.3K
PPLI
1123
People Inc
PPLI
$3.15B
$120K ﹤0.01%
3,000
JRS icon
1124
Nuveen Real Estate Income Fund
JRS
$257M
$120K ﹤0.01%
16,020
IGIC icon
1125
International General Insurance
IGIC
$1.23B
$119K ﹤0.01%
4,927
-691
-12% -$16.9K

Similar funds

Geneos Wealth Management's Q1 2026 Portfolio in Review

As of Q1 2026, Geneos Wealth Management held 2,575 positions worth $4.31B, up 5.4% from $4.09B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $277M of net new capital in Q1 2026, opening 116 new positions and adding to 713 existing holdings. Its largest new stake was iShares Systematic Bond ETF: 84,595 shares worth $7.53M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 7.6% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Capital Group Growth ETF, an estimated $27.9M trimmed.

  • Geneos Wealth Management's largest Q1 2026 buy was iShares Systematic Bond ETF: 84,595 shares worth $7.53M.
  • Geneos Wealth Management added most to iShares Core S&P Total US Stock Market ETF in Q1 2026, an estimated $54.8M increase.
  • Geneos Wealth Management's biggest Q1 2026 reduction was Capital Group Growth ETF, cutting an estimated $27.9M.
  • Geneos Wealth Management fully exited AstraZeneca in Q1 2026, selling an estimated $7.53M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $4.31B portfolio in Q1 2026.
  • Geneos Wealth Management opened 116 new positions and closed 110 in Q1 2026.
  • Geneos Wealth Management's portfolio value rose 5.4% quarter-over-quarter to $4.31B.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.